Ottawa biotech firm Avivagen’s revenues slip on mistimed sales cycle
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to
Skip to content
Drew Basek
Ottawa biotech firm Avivagen closes $5.3M financing amid U.S. market push
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round
Get our email updates
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
Campaign to Create Tomorrow
Learn more about The Ottawa Hospital's $500-million fundraising campaign, the largest in our city’s history, which will transform the future of healthcare in Ottawa.
EXPERT BLOGS
Business advisory committee: Giving a voice to the ByWard Market businesses
ByWard Market District Authority
How to optimize your workspace with a hoteling program
Kane Willmott
EVENTS
OBJ news delivered to your inbox
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.